Estimates Revisions Capricor Therapeutics, Inc.
Stocks
CAPR
US14070B3096
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
19:19:43 18/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.825 USD | -8.39% |
|
+72.89% | -76.46% |
| 08-14 | Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes | RE |
| 08-14 | Capricor Therapeutics Shares Surge 98% as FDA Agrees to Review Deramiocel Application Amendment | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CAPR Stock
- Consensus Capricor Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
